查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2110418

2026-2034年酵素結合免疫吸附（ELISA）檢測法全球市場規模、佔有率、趨勢和成長分析報告

Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 225 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球酵素結合免疫吸附檢測法（ELISA）市場預計將從2025年的33.7億美元成長至2034年的63.8億美元，2026年至2034年的複合年成長率（CAGR）為7.35%。由於ELISA在疾病診斷和生物醫學研究中的廣泛應用，全球酵素結合免疫吸附市場正經歷強勁成長。 ELISA是一種用於檢測生物檢體中抗體、抗原和蛋白質的實驗室檢測法，常用於感染疾病、自體免疫疾病和癌症生物標記的診斷。

推動該市場發展的主要因素之一是對準確可靠的診斷測試日益成長的需求。醫療機構和實驗室廣泛使用酵素連結免疫吸附試驗（ELISA），因為其具有高靈敏度和特異性。此外，生物技術研發投入的增加以及先進診斷技術的開發也促進了市場成長。

隨著全球對快速高效診斷解決方案的需求不斷成長，ELISA檢測市場預計將持續成長。檢查室自動化和多重檢測技術的進步有望提高檢測效率。在全球醫療體係日益重視疾病早期檢測和個人化醫療的背景下，ELISA檢測將繼續在診斷和研究中發揮關鍵作用。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：本節詳細評估影響市場成長的主要促進因素、限制因素、機會和挑戰。內容涵蓋技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：我們全面檢驗主要地理區域的市場表現，識別高成長領域和區域趨勢，並深入了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球酵素結合免疫吸附（ELISA）檢測法市場：依方法分類

  • 市場分析、洞察與預測
  • 直接ELISA
  • 間接ELISA
  • 夾心ELISA
  • 競爭性ELISA

第5章：全球酵素結合免疫吸附（ELISA）檢測法市場：依應用分類

  • 市場分析、洞察與預測
  • 疫苗研發
  • 免疫學
  • 診斷
  • 毒理學
  • 藥物監測和製藥業
  • 移植
  • 感染疾病
  • 癌症
  • 蛋白質定量
  • 其他

第6章：全球酵素結合免疫吸附（ELISA）檢測法市場：依技術分類

  • 市場分析、洞察與預測
  • 化學冷光
  • 比色法
  • 螢光法

第7章 全球酵素結合免疫吸附（ELISA）檢測法市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院和診斷中心
  • 研究所

第8章：全球酵素結合免疫吸附（ELISA）檢測法市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Thermo Fisher Scientific Inc
    • Bio-Rad LaboratoriesInc
    • Danaher Corporation
    • PerkinElmerInc
    • Siemens Healthineers AG
    • F. Hoffmann-La Roche Ltd
    • Abbott
    • Merck KGaA
    • BD
    • Bio-Techne Corporation
    • Enzo BiochemInc
    • RayBiotechInc
    • OriGene TechnologiesInc
    • Creative Diagnostics
    • MyBioSourceInc
    • Abcam Limited
    • Elabscience Biotechnology Inc
    • GenScript Biotech Corporation
    • American Laboratory Products Company（ALPCO）
    • BioMerieux
簡介目錄
Product Code: VMR11212124

The global enzyme-linked immunosorbent assay (ELISA) testing market size is expected to reach USD 6.38 Billion in 2034 from USD 3.37 Billion in 2025, growing at a CAGR of 7.35 during 2026-2034.The global enzyme-linked immunosorbent assay (ELISA) testing market is experiencing strong growth due to its widespread use in disease diagnosis and biomedical research. ELISA is a laboratory technique used to detect antibodies, antigens, and proteins in biological samples. It is commonly used in the diagnosis of infectious diseases, autoimmune disorders, and cancer biomarkers.

One of the major drivers of the market is the increasing demand for accurate and reliable diagnostic testing. Healthcare providers and research laboratories rely heavily on ELISA tests because they offer high sensitivity and specificity. Additionally, rising investments in biotechnology research and the development of advanced diagnostic technologies are boosting the market.

In the future, the ELISA testing market is expected to grow as demand for rapid and efficient diagnostic solutions increases worldwide. Advances in laboratory automation and multiplex testing technologies are likely to enhance testing efficiency. As global healthcare systems emphasize early disease detection and personalized medicine, ELISA testing will continue to play a crucial role in diagnostics and research.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Method

  • Direct ELISA
  • Indirect ELISA
  • Sandwich ELISA
  • Competitive ELISA

By Application

  • Vaccine Development
  • Immunology
  • Diagnostics
  • Toxicology
  • Drug Monitoring & Pharmaceutical Industry
  • Transplantation
  • Infectious Diseases
  • Cancer
  • Protein Quantitation
  • Others

By Technology

  • Chemiluminescent
  • Colorimetric
  • Fluorescent

By End User

  • Hospitals & Diagnostic Centers
  • Research Laboratories

COMPANIES PROFILED

  • Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, PerkinElmer, Inc., Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Abbott, Merck KGaA, BD, Bio-Techne Corporation, Enzo Biochem, Inc., RayBiotech, Inc., OriGene Technologies, Inc., Creative Diagnostics, MyBioSource, Inc., Abcam Limited, Elabscience Biotechnology Inc., GenScript Biotech Corporation, American Laboratory Products Company (ALPCO), BioMerieux

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING MARKET: BY METHOD 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Method
  • 4.2. Direct ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Indirect ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Sandwich ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Competitive ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Vaccine Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Toxicology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Drug Monitoring & Pharmaceutical Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Transplantation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.8. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.9. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.10. Protein Quantitation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.11. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Technology
  • 6.2. Chemiluminescent Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Colorimetric Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Fluorescent Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING MARKET: BY END USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End User
  • 7.2. Hospitals & Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Research Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Method
    • 8.2.2 By Application
    • 8.2.3 By Technology
    • 8.2.4 By End User
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Method
    • 8.3.2 By Application
    • 8.3.3 By Technology
    • 8.3.4 By End User
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Method
    • 8.4.2 By Application
    • 8.4.3 By Technology
    • 8.4.4 By End User
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Method
    • 8.5.2 By Application
    • 8.5.3 By Technology
    • 8.5.4 By End User
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Method
    • 8.6.2 By Application
    • 8.6.3 By Technology
    • 8.6.4 By End User
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Thermo Fisher Scientific Inc
    • 10.2.2 Bio-Rad LaboratoriesInc
    • 10.2.3 Danaher Corporation
    • 10.2.4 PerkinElmerInc
    • 10.2.5 Siemens Healthineers AG
    • 10.2.6 F. Hoffmann-La Roche Ltd
    • 10.2.7 Abbott
    • 10.2.8 Merck KGaA
    • 10.2.9 BD
    • 10.2.10 Bio-Techne Corporation
    • 10.2.11 Enzo BiochemInc
    • 10.2.12 RayBiotechInc
    • 10.2.13 OriGene TechnologiesInc
    • 10.2.14 Creative Diagnostics
    • 10.2.15 MyBioSourceInc
    • 10.2.16 Abcam Limited
    • 10.2.17 Elabscience Biotechnology Inc
    • 10.2.18 GenScript Biotech Corporation
    • 10.2.19 American Laboratory Products Company (ALPCO)
    • 10.2.20 BioMerieux